Last reviewed · How we verify

NCT05741593: QUATRO

Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.

Recruiting now Last updated 18 November 2024
What this trial tests

trial testing Analysis of the verbatim from the transcription of the recorded interviews. in Stroke in 30 participants. Currently enrolling.

Timeline
1 April 2025
Primary endpoint
1 April 2026
1 April 2026

Quick facts

Lead sponsorHospices Civils de Lyon
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment30
Start date1 April 2025
Primary completion1 April 2026
Estimated completion1 April 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

Adults 65 to 100, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05741593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing